FinkelsteinWIsselbacherKJ. Cimetidine. N Engl J Med1978; 299: 992–6.
2.
HennRMIsenbergJIMaxwellV. Inhibition of gastric acid secretion by cimetidine in patients with duodenal ulcer. N Engl J Med1975; 293: 371–5.
3.
CoccoAECoccoDV. A survey of cimetidine prescribing. N Engl J Med1981; 304: 1281.
4.
UlaszekKMSeabloomKDSamplinerRDJonesWN. Appropriateness of long-term cimetidine prescribing. Drug Intell Clin Pharm1984; 18: 623–5.
5.
ZellSCarmichaelJMReddyAN. Rational approach to long term use of H2-antagonists. Am J Med1987; 82: 796–802.
6.
KrussDMLittmanA. Safety of cimetidine. Gastroenterology1978; 74: 478–83.
7.
Cimetidine and gastric cancer: A reappraisal. Drug Ther Bull1983; 21: 65–7.
8.
SmithieFOchsnerAJ. Cancer of the stomach. Philadelphia: W.B. Saunders, 1916: 350–73.
9.
McCreaED. Gastric carcinoma with duodenal ulcer. Br Med J1935; 1: 252.
10.
EpsteinHJMendellTH. Coexistence of duodenal ulcer with independent gastric carcinoma. Gastroenterology1950; 16: 602–8.
11.
RyanEPBealJM. The development of carcinoma of the stomach in patients with duodenal ulcer. Surgery1957; 42: 271–5.
12.
BatesonEM. Cancer of the stomach and duodenal ulcer: Report of two cases with a discussion of the significance of this rare association. Clin Radiol1972; 23: 208–12.
13.
PapachristouDNAgnantiNFortnerJG. Gastric carcinoma after treatment of ulcer. Am J Surg1980; 139: 193–6.
14.
LewisJHWoodsM. Gastric carcinoma in patients with unoperated duodenal ulcer disease. Am J Gastroenterol1977; 77: 368–73.
15.
TaylorRHLovellDMenzies-GowNLaBrooySJMisiewiczJJ. Misleading response of malignant gastric ulcers to cimetidine (letter). Lancet1978; 1: 686–7.
16.
MurrayCChapmanRIsaacsonPBamforthJ. Cimetidine and malignant gastric ulcers (letter). Lancet1978; 1: 1092.
17.
MinoliGTerruziVRossiniA. Cimetidine and malignant gastric ulcers (letter). Lancet1978; 1: 1092.
18.
WelshCLCravenJLHoptonD. Cimetidine in alleviation of gastric cancer pain (letter). Br Med J1977; 1: 1413.
19.
GlynnLE, ed. Tissue repair and regeneration. Amsterdam: Elsevier, 1981: 309–42.
MuscroftTJBurdonDWYoungsDJKeighleyMRB. Cimetidine is unlikely to increase formation of intragastric N-nitroso-compounds in patients taking a normal diet. Lancet1981; 1: 408–10.
25.
International Agency for Research on Cancer Working Group on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Some pharmaceutical drugs. Albany, NY: World Health Organization, 1980: 297–8.
ElderJBGanguliPCGillespieIE. Gastric cancer in patients who have taken cimetidine (letter). Lancet1979; 2: 245.
30.
JensenDEMageePN. Methylation of DNA by nitrosocimetidine in vitro. Cancer Res1981; 41: 230–6.
31.
IchinotsuboDMacKinnonALiuC. Mutagenicity of nitrosated cimetidines. Carcinogenesis1981; 41: 230–6.
32.
GombarCTMageePN. DNA-methylation by nitrosocimetidine and N-methyl-N'-nitro-N-nitrosoguanidine in the intact rat. Chem Biol Interact1982; 40; 149–57.
33.
SchwartzMHummelJEisenbrandG. Induction of DNA strand breaks by nitrosocimetidine. Cancer Lett1980; 10: 223–8.
34.
BarrowsLRGombarCTMageePN. Mutation, DNA labeling, and transformation of BHK-21/CL 13 cells by MNNG and nitrosocimetidine. Mutat Res1982; 102: 145–58.
35.
AthansiouKKurtopoulosSA. Induction of sister chromatid exchanges and chromosome aberrations in cultured mammalian cells by N-nitrosocimetidine. Cancer Lett1981; 14: 71–5.
36.
InuiNKurokiTYamadaMA, eds. Mutation, promotion, and transformation in vitro. Tokyo: Japanese Scientific Press, 1980: 109–24.
37.
LijinskyWReubeerMD. Comparison of nitrosocimetidine with nitrosomethylnitroguanidine in chronic feeding tests in rats. Cancer Res1984; 44: 447–9.
38.
MageePN, ed. Nitrosamines and human cancer. Cold Springs Harbor, NY: Cold Springs Harbor Laboratory, 1982: 403–5.
39.
LeslieGBNoakesDNPollittFDRoeFJCWalkerTF. A two-year study with cimetidine in the rat: Assessment for chronic toxicity and carcinogenicity. Toxicol Appl Pharmacol1981; 61: 119–37.
40.
AndersonLMGiner-SorollaAHallerIMBudingerJM. Effects of cimetidine, nitrite, cimetidine plus nitrite, and nitrosocimetidine on tumors in mice following transplacental plus chronic lifetime exposure. Cancer Res1985; 45: 3561–6.
41.
CreanGPLeslieGBRoeFJC. Cimetidine and gastric cancer: Negative studies in dogs (letter). Lancet1976; 2: 797–8.
42.
CreanGPLeslieGBWalkerTF. Safety evaluation of cimetidine: 54 month interim report on long term study in dogs. J Appl Toxicol1981; 1: 159–64.
43.
Colin-JonesJGLangmanMJSLawsonDHVesseyMP. Cimetidine and gastric cancer: Preliminary report from post-marketing surveillance study. Br Med J1982; 285: 1311–3.
44.
JensenDE. Denitrosation as a determinant of nitrosocimetidine in vivo activity. Cancer Res1983; 43: 5258–67.